199 related articles for article (PubMed ID: 17244030)
1. Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions.
Reinisch CM; Uthman A; Erovic BM; Pammer J
J Cutan Pathol; 2007 Feb; 34(2):174-80. PubMed ID: 17244030
[TBL] [Abstract][Full Text] [Related]
2. Maspin expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
[TBL] [Abstract][Full Text] [Related]
3. p63 expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
[TBL] [Abstract][Full Text] [Related]
4. Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells.
Wang Q; Li WL; You P; Su J; Zhu MH; Xie DF; Zhu HY; He ZY; Li JX; Ding XY; Wang X; Hu YP
J Cell Biochem; 2009 Jan; 106(1):16-24. PubMed ID: 19021148
[TBL] [Abstract][Full Text] [Related]
5. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival.
Kang MK; Kim RH; Kim SJ; Yip FK; Shin KH; Dimri GP; Christensen R; Han T; Park NH
Br J Cancer; 2007 Jan; 96(1):126-33. PubMed ID: 17179983
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis.
Lee K; Adhikary G; Balasubramanian S; Gopalakrishnan R; McCormick T; Dimri GP; Eckert RL; Rorke EA
J Invest Dermatol; 2008 Jan; 128(1):9-17. PubMed ID: 17625597
[TBL] [Abstract][Full Text] [Related]
7. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
8. Immunocyto- and histochemical profiling of nucleostemin expression: marker of epidermal stem cells?
Lacina L; Smetana K; Dvoránková B; Stork J; Plzáková Z; Gabius HJ
J Dermatol Sci; 2006 Nov; 44(2):73-80. PubMed ID: 17000083
[TBL] [Abstract][Full Text] [Related]
9. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 protein in benign and malignant epidermal pathologic conditions.
Helander SD; Peters MS; Pittelkow MR
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):741-8. PubMed ID: 8227547
[TBL] [Abstract][Full Text] [Related]
11. Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.
Ruchusatsawat K; Wongpiyabovorn J; Protjaroen P; Chaipipat M; Shuangshoti S; Thorner PS; Mutirangura A
Hum Pathol; 2011 Dec; 42(12):1878-87. PubMed ID: 21663940
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
[TBL] [Abstract][Full Text] [Related]
13. Epidermal fatty-acid-binding protein in psoriasis, basal and squamous cell carcinomas: an immunohistological study.
Masouyé I; Saurat JH; Siegenthaler G
Dermatology; 1996; 192(3):208-13. PubMed ID: 8726632
[TBL] [Abstract][Full Text] [Related]
14. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin.
Lymboussaki A; Kaipainen A; Hatva E; Västrik I; Jeskanen L; Jalkanen M; Werner S; Stenbäck F; Alitalo R
Br J Cancer; 1996 Jun; 73(11):1347-55. PubMed ID: 8645578
[TBL] [Abstract][Full Text] [Related]
15. GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.
Kim HS; Shin MS; Cheon MS; Kim JW; Lee C; Kim WH; Kim YS; Jang BG
PLoS One; 2017; 12(3):e0174565. PubMed ID: 28346486
[TBL] [Abstract][Full Text] [Related]
16. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: overexpression and redistribution in psoriasis and cutaneous carcinomas.
Moussali H; Bylaite M; Welss T; Abts HF; Ruzicka T; Walz M
Exp Dermatol; 2005 Jun; 14(6):420-8. PubMed ID: 15885077
[TBL] [Abstract][Full Text] [Related]
17. Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis.
Affara NI; Trempus CS; Schanbacher BL; Pei P; Mallery SR; Bauer JA; Robertson FM
Anticancer Res; 2006; 26(4B):2805-20. PubMed ID: 16886599
[TBL] [Abstract][Full Text] [Related]
18. Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin.
Ghali L; Wong ST; Green J; Tidman N; Quinn AG
J Invest Dermatol; 1999 Oct; 113(4):595-9. PubMed ID: 10504446
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases.
Piepkorn M
Am J Dermatopathol; 1996 Apr; 18(2):165-71. PubMed ID: 8739992
[TBL] [Abstract][Full Text] [Related]
20. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
Kanoh M; Amoh Y; Sato Y; Katsuoka K
Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
